The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes
Open accessAbstract
We investigated SARS-CoV-2 potential tropism by surveying expression of viral entry-associated genes in single-cell RNA-sequencing data from multiple tissues from healthy human donors. We co-detected these transcripts in specific respiratory, corneal and intestinal epithelial cells, potentially explaining the high efficiency of SARS-CoV-2 transmission. These genes are co-expressed in nasal epithelial cells with genes involved in innate immunity, highlighting the cells’ potential role in initial viral infection, spread and clearance. The study offers a useful resource for further lines of inquiry with valuable clinical samples from COVID-19 patients and we provide our data in a comprehensive, open and user-friendly fashion at www.covid19cellatlas.org . An analysis of single-cell transcriptomics datasets from different tissues shows that ACE2 and TMPRSS2 are co-expressed in respiratory, corneal and intestinal epithelial cell populations, and that respiratory expression of ACE2 is associated with genes involved in innate immunity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although scSeq revealed ACE2 transcripts in only a subset of OE cells, this low level of observed expression matches or exceeds that observed in respiratory cells types that are infected by CoV-2 in COVID-19 patients (39) (Fig. 3).”
From Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia (2020) · cites this paper as [39]
Experimental — accuracy not yet measuredIn the citing paper
“Probably most important for the high efficacy of SARS-CoV-2 transmission is the high co-expression of ACE2 and TMPRSS2 in nasal epithelial cells, particularly in two types of goblet cells and a subset of ciliated cells, showing the highest expression among all cells in the respiratory tree (Figure 2 A).”
From COVID-19 and the human innate immune system (2021) · cites this paper as Sungnak et al., 2020
In the citing paper
“An interesting observation of this study was the high co-expression of genes involved in early steps of antiviral immune responses in these epithelial cells, which indicated the potential for these specialized nasal cells to play an important role in the initial viral infection, spread, but potentially also, clearance.”
From COVID-19 and the human innate immune system (2021) · cites this paper as Sungnak et al., 2020
In the citing paper
“TMPRSS2 is more widely expressed than ACE2, and cells with simultaneous expression were identified in the respiratory tree, the cornea, esophagus, ileum, colon, gallbladder, and common bile duct (Sungnak et al., 2020), yet there was no evidence for simultaneous expression in immune cells.”
From COVID-19 and the human innate immune system (2021) · cites this paper as Sungnak et al., 2020
In the citing paper
“It has recently been demonstrated through single cell RNA sequencing analysis (referred to herein as scSeq) that cells from the human upper airway — including nasal RE goblet and ciliated cells —express high levels of ACE2 and TMPRSS2, suggesting that these RE cell types may serve as a viral reservoir during CoV-2 infection (39, 40).”
From Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia (2020) · cites this paper as [39]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
A novel coronavirus from patients with pneumonia in China, 2019
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001017 · Cited by 28,244
Clinical Characteristics of Coronavirus Disease 2019 in China
Eastin, C., & Eastin, T. (2020) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2020.04.004 · Cited by 24,945
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia
Li, Q., Guan, X., Wu, P., Wang, X., Zhou, L., Tong, Y., Ren, R., Leung, K. S. M., Lau, E. H. Y., Wong, J. Y., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001316 · Cited by 16,575
Integrating single-cell transcriptomic data across different conditions, technologies, and species
Butler, A., Hoffman, P., Smibert, P., Papalexi, E., & Satija, R. (2018) · Nature Biotechnology · doi:10.1038/nbt.4096 · Cited by 13,174
Fast, sensitive and accurate integration of single-cell data with Harmony
Korsunsky, I., Millard, N., Fan, J., Slowikowski, K., Zhang, F., Wei, K., Baglaenko, Y., Brenner, M., Loh, P.-R., & Raychaudhuri, S. (2019) · Nature Methods · doi:10.1038/s41592-019-0619-0 · Cited by 10,488
Cited by
Sorted by citations
Items 701–800 of 1,000
Goblet Cell Hyperplasia Increases SARS-CoV-2 Infection in Chronic Obstructive Pulmonary Disease
Osan, J. K., Talukdar, S. N., Feldmann, F., DeMontigny, B. A., Jerome, K., Bailey, K. L., Feldmann, H., & Mehedi, M. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.00459-22 · Cited by 38
Stay (GI) Healthy: COVID-19 and Gastrointestinal Manifestations
Vespa, E., Pugliese, N., Colapietro, F., & Aghemo, A. (2021) · Techniques and Innovations in Gastrointestinal Endoscopy · doi:10.1016/j.tige.2021.01.006 · Cited by 37
Aiello, A., Fard, S. N., & Goletti, D. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1244556 · Cited by 38
Role of pharmacists during the COVID ‐19 pandemic in China‐Shanghai experiences
Liao, Y., Ma, C.-L., Lau, A. H., & Zhong, M. (2020) · JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY · doi:10.1002/jac5.1288 · Cited by 37
Are eyes the windows to COVID-19? Systematic review and meta-analysis
Nora, R. L. D., Putera, I., Khalisha, D. F., Septiana, I., Ridwan, A. S., & Sitompul, R. (2020) · BMJ Open Ophthalmology · doi:10.1136/bmjophth-2020-000563 · Cited by 37
Lv, H., Zhang, W., Zhu, Z., Xiong, Q., Xiang, R., Wang, Y., Shi, W., Deng, Z., & Xu, Y. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.09.039 · Cited by 37
Pagano, G., Manfredi, C., Pallardó, F. V., Lyakhovich, A., Tiano, L., & Trifuoggi, M. (2020) · Inflammation Research · doi:10.1007/s00011-020-01423-0 · Cited by 39
Atyeo, C. G., Slein, M. D., Fischinger, S., Burke, J. S., Schäfer, A., Leist, S. R., Kuzmina, N. A., Mire, C. E., Honko, A. N., Johnson, R. I., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.143129 · Cited by 37
Effect of aspirin on short-term outcomes in hospitalized patients with COVID-19
Sahai, A., Bhandari, R., Godwin, M., McIntyre, T. M., Chung, M. K., Iskandar, J., Kamran, H., Hariri, E. H., Aggarwal, A., Burton, R., et al. (2021) · Vascular Medicine · doi:10.1177/1358863x211012754 · Cited by 38
Zhang, F., Li, W., Feng, J., da Silva, S. R., Ju, E., Zhang, H., Chang, Y., Moore, P. S., Guo, H., & Gao, S. (2021) · Journal of Medical Virology · doi:10.1002/jmv.27244 · Cited by 38
Winkley, K., Banerjee, D., Louiselle, D. A., Biswell, R. L., Posey, N., Fatheree, K., McDanel, S., Bradley, T., Moffatt, M. E., Koseva, B. S., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-95532-3 · Cited by 37
Gastrointestinal mucosal immunity and COVID-19
Velikova, T. V., Snegarova, V., Kukov, A., Batselova, H., Mihova, A., & Nakov, R. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i30.5047 · Cited by 37
COVID-19 Is a Multi-Organ Aggressor: Epigenetic and Clinical Marks
Kgatle, M., Lawal, I. O., Mashabela, G. T., Boshomane, T. M. G., Koatale, P. C., Mahasha, P. W., Ndlovu, H., Vorster, M., Rodrigues, H. G., Zeevaart, J. R., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.752380 · Cited by 37
Kageyama, Y., Nishizaki, Y., Aida, K., Yayama, K., Ebisui, T., Akiyama, T., & Nakamura, T. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.10942 · Cited by 37
Higashikuni, Y., Liu, W., Obana, T., & Sata, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222112081 · Cited by 38
Gilbert, C., Lefeuvre, C., Preisser, L., Pivert, A., Soleti, R., Blanchard, S., Delneste, Y., Ducancelle, A., Couez, D., & Jeannin, P. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.750279 · Cited by 40
Pivniouk, V. I., Pivniouk, O., DeVries, A., Uhrlaub, J. L., Michael, A., Pivniouk, D., VanLinden, S. R., Conway, M., Hahn, S., Malone, S. P., et al. (2021) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2021.11.019 · Cited by 39
Dissecting the Molecular Mechanisms Surrounding Post-COVID-19 Syndrome and Neurological Features
Mohamed, M. S., Johansson, A., Jonsson, J., & Schiöth, H. B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084275 · Cited by 37
Kalejaiye, T. D., Bhattacharya, R., Burt, M. A., Travieso, T., Okafor, A. E., Mou, X., Blasi, M., & Musah, S. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.855340 · Cited by 38
Risk assessment for long- and short-range airborne transmission of SARS-CoV-2, indoors and outdoors
Poydenot, F., Abdourahamane, I., Caplain, E., Der, S., Haiech, J., Jallon, A., Khoutami, I., Loucif, A., Marinov, E., & Andreotti, B. (2022) · PNAS Nexus · doi:10.1093/pnasnexus/pgac223 · Cited by 42
Al-Qahtani, A. A., Pantazi, I., Alhamlan, F. S., Alothaid, H., Matou‐Nasri, S., Sourvinos, G., Vergadi, E., & Tsatsanis, C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1020624 · Cited by 37
Recent advances in respiratory immunization: A focus on COVID-19 vaccines
He, X., Chen, X., Wang, H., Du, G., & Sun, X. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.02.011 · Cited by 37
Ocular manifestations of COVID-19: a literature review
Torres, B. R. S., da Cunha, C. E. X., Castro, L. R., de Brito, L. M. P., Ferreira, C. V. O., & Ribeiro, M. V. M. R. (2020) · Revista da Associação Médica Brasileira · doi:10.1590/1806-9282.66.9.1296 · Cited by 36
Hung, D. L. L., Li, X., Chiu, K. H., Yip, C. C., To, K. K., Chan, J. F., Sridhar, S., Chung, T. W., Lung, K.-C., Liu, R. W. T., et al. (2020) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaa210 · Cited by 36
Single Virus Targeting Multiple Organs: What We Know and Where We Are Heading?
Prasad, A., & Prasad, M. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00370 · Cited by 36
Saksena, N. K., Bonam, S. R., & Saksena, M. M. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.581726 · Cited by 36
Yang, J., & Yan, H. (2021) · Cellular and Molecular Immunology · doi:10.1038/s41423-021-00650-7 · Cited by 37
Risk factors for pulmonary embolism in patients with COVID-19: a systemic review and meta-analysis
Cui, Y., Cheng, W., Mou, Z., Xiao, D., Li, Y., Li, Y., Li, W.-T., & Chen, Z. (2021) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2021.08.017 · Cited by 37
Determinants of expression of SARS‐CoV‐2 entry‐related genes in upper and lower airways
Aliee, H., Massip, F., Qi, C., de Biase, M. S., van Nijnatten, J., Kersten, E. T. G., Kermani, N. Z., Khuder, B., Vonk, J. M., Vermeulen, R. C. H., et al. (2021) · Allergy · doi:10.1111/all.15152 · Cited by 38
VLP-Based COVID-19 Vaccines: An Adaptable Technology against the Threat of New Variants
Prates-Syed, W. A., Chaves, L. C. S., Crema, K. P., Vuitika, L., Lira, A. A. D. L., Côrtes, N., Kersten, V., Guimarães, F. E. G., Sadraeian, M., da Silva, F. L. B., et al. (2021) · Vaccines · doi:10.3390/vaccines9121409 · Cited by 36
Head, R. J., Lumbers, E. R., Jarrott, B., Tretter, F., Smith, G., Pringle, K. G., Islam, S., & Martin, J. H. (2022) · Pharmacology Research & Perspectives · doi:10.1002/prp2.922 · Cited by 36
SARS-CoV-2 Variants of Concern Hijack IFITM2 for Efficient Replication in Human Lung Cells
Nchioua, R., Schundner, A., Kmieć, D., Bozzo, C. P., Zech, F., Koepke, L., Graf, A., Krebs, S., Blum, H., Frick, M., et al. (2022) · Journal of Virology · doi:10.1128/jvi.00594-22 · Cited by 38
Revealing the mystery of persistent smell loss in long COVID patients
Park, J. W., Wang, X., & Xu, R. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.73485 · Cited by 38
Zarkoob, H., Allué‐Guardia, A., Chen, Y., Garcia‐Vilanova, A., Jung, O., Coon, S. L., Song, M. J., Park, J., Oladunni, F. S., Miller, J., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-03753-7 · Cited by 37
Assessment of Microbiota in the Gut and Upper Respiratory Tract Associated with SARS-CoV-2 Infection
Li, J., Jing, Q., Li, J., Hua, M., Di, L., Song, C., Huang, Y., Wang, J., Chen, C., & Wu, A. R. (2020) · Microbiome · doi:10.1186/s40168-022-01447-0 · Cited by 36
Resistance of endothelial cells to SARS-CoV-2 infection in vitro
Ahmetaj‐Shala, B., Peacock, T. P., Baillon, L., Swann, O. C., Gashaw, H. H., Rustagi, A., Barclay, W., & Mitchell, J. A. (2025) · Journal of Virology · doi:10.1128/jvi.01205-25 · Cited by 36
Poyatos, P., Luque, N., Sabater, G., Eizaguirre, S., Bonnin, M., Orriols, R., & Tura-Ceide, O. (2024) · Infection · doi:10.1007/s15010-024-02173-5 · Cited by 35
Machine learning integrative approaches to advance computational immunology
Curion, F., & Theis, F. J. (2024) · Genome Medicine · doi:10.1186/s13073-024-01350-3 · Cited by 36
Sars-CoV-2 and black population: ACE2 as shield or blade?
Vinciguerra, M., & Greco, E. (2020) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2020.104361 · Cited by 35
Heck, T. G., Ludwig, M. S., Frizzo, M. N., Rasia‐Filho, A. A., & de Bittencourt, P. I. H. (2020) · Clinical Science · doi:10.1042/cs20200596 · Cited by 36
Targeting Crucial Host Factors of SARS-CoV-2
Tharappel, A. M., Samrat, S. K., Li, Z., & Li, H. (2020) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.0c00456 · Cited by 36
Wang, M., Bu, X., Fang, G., Luan, G., Huang, Y., Akdiş, C. A., Wang, C., & Zhang, L. (2020) · Allergy · doi:10.1111/all.14665 · Cited by 35
Can Natural Killer Cells Be a Principal Player in Anti-SARS-CoV-2 Immunity?
Ahmed, F. N., Jo, D., & Lee, S. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.586765 · Cited by 36
Markers Associated with COVID-19 Susceptibility, Resistance, and Severity
Fakhroo, A. D., Thani, A. A. A., & Yassine, H. M. (2020) · Viruses · doi:10.3390/v13010045 · Cited by 38
Mediators of SARS-CoV-2 entry are preferentially enriched in cardiomyocytes
Yang, J., Chen, T., & Zhou, Y. (2021) · Hereditas · doi:10.1186/s41065-020-00168-4 · Cited by 35
Detecting the Multiomics Signatures of Factor-Specific Inflammatory Effects on Airway Smooth Muscles
Zhang, Y., Li, Z., Zeng, T., Chen, L., Li, H., Huang, T., & Cai, Y. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2020.599970 · Cited by 35
Mitamura, Y., Schulz, D., Oro, S., Li, N., Kolm, I., Lang, C. C. V., Ziadlou, R., Tan, G., Bodenmiller, B., Steiger, P., et al. (2021) · Allergy · doi:10.1111/all.14983 · Cited by 35
The Transmission of SARS-CoV-2 Infection on the Ocular Surface and Prevention Strategies
Kitazawa, K., Deinhardt‐Emmer, S., Inomata, T., Deshpande, S., & Sotozono, C. (2021) · Cells · doi:10.3390/cells10040796 · Cited by 35
Rethinavel, H. S., Ravichandran, S., Radhakrishnan, R. K., & Kandasamy, M. (2021) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2021.101965 · Cited by 36
Zhou, Y., Wang, M., Li, Y., Wang, P., Zhao, P., Yang, Z., Wang, S., Zhang, L., Li, Z., Jia, K., et al. (2021) · Immunology Letters · doi:10.1016/j.imlet.2021.06.008 · Cited by 36
Sherman, E. J., & Emmer, B. T. (2021) · Scientific Reports · doi:10.1038/s41598-021-95308-9 · Cited by 40
Genetic landscape of the ACE2 coronavirus receptor
Yang, Z., Macdonald-Dunlop, E., Chen, J., Prins, B. P., Wheeler, E., Pietzner, M., Peters, J. E., Langenberg, C., Butterworth, A. S., Reiner, A. P., et al. (2022) · Apollo (University of Cambridge) · doi:10.17863/cam.84347 · Cited by 35
COVID-19 and the Immune Response: A Multi-Phasic Approach to the Treatment of COVID-19
Sapir, T., Averch, Z., Lerman, B., Bodzin, A., Fishman, Y., & Maitra, R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158606 · Cited by 34
ACE2 partially dictates the host range and tropism of SARS-CoV-2
Gao, S., & Zhang, L. (2020) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2020.11.032 · Cited by 35
Leeming, D. J., Genovese, F., Sand, J. M. B., Rasmussen, D. G. K., Christiansen, C., Jenkins, G. R., Maher, T. M., Vestbo, J., & Karsdal, M. A. (2021) · Respiratory Research · doi:10.1186/s12931-020-01590-y · Cited by 37
Strohl, W. R., Ku, Z., An, Z., Carroll, S. F., Keyt, B. A., & Strohl, L. M. (2022) · BioDrugs · doi:10.1007/s40259-022-00529-7 · Cited by 35
Altered gut microbiota patterns in COVID-19: Markers for inflammation and disease severity
Chakraborty, C., Sharma, A. R., Bhattacharya, M., Dhama, K., & Lee, S. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i25.2802 · Cited by 35
Zhao, Y., Ni, W., Liang, S., Dong, L., Xiang, M., Cai, Z., Niu, D., Zhang, Q., Wang, D., Zheng, Y., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.abo3332 · Cited by 34
Consensus transcriptional regulatory networks of coronavirus-infected human cells
Ochsner, S. A., Pillich, R., & McKenna, N. J. (2020) · Scientific Data · doi:10.1038/s41597-020-00628-6 · Cited by 35
Dermatological aspects of SARS-CoV-2 infection: mechanisms and manifestations
Garduño-Soto, M., Choreño-Parra, J. A., & Cazarin-Barrientos, J. R. (2020) · Archives of Dermatological Research · doi:10.1007/s00403-020-02156-0 · Cited by 33
The anti‐inflammatory and antiviral properties of anionic pulmonary surfactant phospholipids
Numata, M., Kandasamy, P., & Voelker, D. R. (2023) · Immunological Reviews · doi:10.1111/imr.13207 · Cited by 33
2020 update on human coronaviruses: One health, one world
Zhao, X., Ding, Y., Du, J., & Fan, Y. (2020) · Medicine in Novel Technology and Devices · doi:10.1016/j.medntd.2020.100043 · Cited by 36
Desai, M., & Oppenheimer, J. J. (2020) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2020.10.036 · Cited by 33
Gransagne, M., Aymé, G., Brier, S., Friec, G. C.-L., Mériaux, V., Nowakowski, M., Déjardin, F., Levallois, S., de Melo, G. D., Donati, F., et al. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101290 · Cited by 33
Identification of potent small molecule inhibitors of SARS-CoV-2 entry
Mediouni, S., Mou, H., Otsuka, Y., Jablonski, J. A., Adcock, R. S., Batra, L., Chung, D.-H., Rood, C., de Vera, I. M. S., Rahaim, R. J. J., et al. (2022) · SLAS DISCOVERY · doi:10.1016/j.slasd.2021.10.012 · Cited by 33
Spatial region-resolved proteome map reveals mechanism of COVID-19-associated heart injury
Leng, L., Ma, J., Zhang, P., Xu, S., Li, X., Jin, Y. H., Cai, J., Tang, R., Zhao, L., He, Z., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110955 · Cited by 33
Highly resolved spatial transcriptomics for detection of rare events in cellsPreprint
Groiss, S., Pabst, D., Faber, C., Meier, A., Bogdoll, A., Unger, C., Nilges, B. S., Strauß, S., Föderl-Höbenreich, E., Hardt, M., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.10.11.463936 · Cited by 35
Cardoso, C. C., Rossi, Á. D., Galliez, R. M., Faffe, D. S., Tanuri, A., & Castiñeiras, T. M. P. P. (2022) · JAMA · doi:10.1001/jama.2022.11006 · Cited by 32
Liu, X., Xiong, W., Ye, M., Lu, T., Yuan, K., Chang, S., Han, Y., Wang, Y., Lü, L., & Bao, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01669-0 · Cited by 34
Lawrenson, J. G., & Buckley, R. (2020) · Ophthalmic and Physiological Optics · doi:10.1111/opo.12708 · Cited by 32
ACEI/ARB therapy in COVID-19: the double-edged sword of ACE2 and SARS-CoV-2 viral docking
Onweni, C. L., Zhang, Y. S., Caulfield, T. R., Hopkins, C. E., Fairweather, D., & Freeman, W. D. (2020) · Critical Care · doi:10.1186/s13054-020-03195-9 · Cited by 32
Antiviral and healing potential of Sambucus nigra extracts
Bartak, M., Lange, A., Słońska, A., & Cymerys, J. (2020) · Bionatura · doi:10.21931/rb/2020.05.03.18 · Cited by 32
Hathout, R. M., AbdelHamid, S. G., & Metwally, A. A. (2020) · Informatics in Medicine Unlocked · doi:10.1016/j.imu.2020.100446 · Cited by 32
SARS-CoV-2 Infection in Cancer Patients: Effects on Disease Outcomes and Patient Prognosis
Seth, G., Sethi, S., Bhattarai, S., Saini, G., Singh, C. B., & Aneja, R. (2020) · Cancers · doi:10.3390/cancers12113266 · Cited by 32
Zhang, G., Wu, Y., Xu, R., & Du, X. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26695 · Cited by 32
Müller, W. E. G., Neufurth, M., Wang, S., Tan, R., Schröder, H. C., & Wang, X. (2020) · Marine Drugs · doi:10.3390/md18120639 · Cited by 32
Bukowska‐Ośko, I., Popiel, M., & Kowalczyk, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115799 · Cited by 32
Occupational and environmental exposure to SARS-CoV-2 in and around infected mink farms
de Rooij, M. M. T., der Honing, R. W. H., Hulst, M., Harders, F., Engelsma, M. Y., van de Hoef, W., Meliefste, K., Nieuwenweg, S., Munnink, B. B. O., van Schothorst, I., et al. (2021) · Occupational and Environmental Medicine · doi:10.1136/oemed-2021-107443 · Cited by 32
COVID-19 and Neurodegenerative Diseases: Prion-Like Spread and Long-Term Consequences
Baazaoui, N., & Iqbal, K. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220105 · Cited by 35
Hoque, M. N., Sarkar, M. M. H., Khan, M. A., Hossain, M. A., Hasan, M. I., Rahman, M. H., Habib, M. A., Akter, S., Banu, T. A., Goswami, B., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.918692 · Cited by 32
Innate immune recognition against SARS-CoV-2
Yamada, T., & Takaoka, A. (2023) · Inflammation and Regeneration · doi:10.1186/s41232-023-00259-5 · Cited by 33
Post Acute Corona Virus (Covid-19) Syndrome
Timewar, R. R., Sumar, A. I., Kohale, N. B., Rathod, S. B., & Manwar, G. G. (2023) · International Journal of Advanced Research in Science Communication and Technology · doi:10.48175/ijarsct-8842 · Cited by 32
A single-cell RNA expression map of human coronavirus entry factorsPreprint
Singh, M., Bansal, V., & Feschotte, C. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.08.084806 · Cited by 33
NETosis: A key player in autoimmunity, COVID-19, and long COVID
Monsalve, D. M., Acosta‐Ampudia, Y., Acosta, N. G., Celis-Andrade, M., Şahin, A., Morva, A., Shoenfeld, Y., & Ramı́rez-Santana, C. (2025) · Journal of Translational Autoimmunity · doi:10.1016/j.jtauto.2025.100280 · Cited by 32
SARS-CoV-2 infection and stem cells: Interaction and intervention
Yu, F., Jia, R., Tang, Y., Liu, J., & Wei, B. (2020) · Stem Cell Research · doi:10.1016/j.scr.2020.101859 · Cited by 31
Murillo, J., Villegas-Trujillo, L. M., Ulloa-Murillo, L. M., & Rodríguez, A. (2020) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2020.104162 · Cited by 31
Pandey, A. P., Nikam, A. N., Mutalik, S. P., Fernandes, G. J., Shreya, A. B., Padya, B. S., Raychaudhuri, R., Kulkarni, S., Prassl, R., Subramanian, S., et al. (2020) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.0c01243 · Cited by 31
Santos, J. M. B., Soares, C. P., Monteiro, F. R., Mello, R., do Amaral, J. B., Aguiar, A. S., da Soledade, M. P., Sucupira, C., de Paulis, M., de Andrade, J. B., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.595343 · Cited by 32
Characteristics of COVID-19 smell and taste dysfunction in hospitalized patients
Husain, Q. M., Kokinakos, K., Kuo, Y., Zaidi, F., Houston, S., & Shargorodsky, J. (2021) · American Journal of Otolaryngology · doi:10.1016/j.amjoto.2021.103068 · Cited by 31
Galati, D., Zanotta, S., Capitelli, L., & Bocchino, M. (2021) · Allergy · doi:10.1111/all.15004 · Cited by 31
Prediction of Non-canonical Routes for SARS-CoV-2 Infection in Human Placenta Cells
Constantino, F. B., Cury, S. S., Nogueira, C. R., Carvalho, R. F., & Justulin, L. A. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.614728 · Cited by 33
Two Different Therapeutic Approaches for SARS-CoV-2 in hiPSCs-Derived Lung Organoids
Spitalieri, P., Centofanti, F., Murdocca, M., Scioli, M. G., Latini, A., Cesare, S. D., Citro, G., Rossi, A., Orlandi, A., Miersch, S., et al. (2022) · Cells · doi:10.3390/cells11071235 · Cited by 31
Protein Expression Profile of ACE2 in the Normal and COVID-19-Affected Human Brain
Lindskog, C., Méar, L., Virhammar, J., Fällmar, D., Kumlien, E., Hesselager, G., Casar‐Borota, O., & Rostami, E. (2022) · Journal of Proteome Research · doi:10.1021/acs.jproteome.2c00184 · Cited by 31
Boeck, I. D., Cauwenberghs, E., Spacova, I., Gehrmann, T., Eilers, T., Delanghe, L., Wittouck, S., Bron, P. A., Henkens, T., Gamgami, I., et al. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.01682-22 · Cited by 31
Vakili, K. G., Fathi, M., Yaghoobpoor, S., Sayehmiri, F., Nazerian, Y., Nazerian, A., Mohamadkhani, A., Khodabakhsh, P., Réus, G. Z., Hajibeygi, R., et al. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.983089 · Cited by 32
Kettunen, P., Lesnikova, A., Räsänen, N., Ojha, R., Palmunen, L., Laakso, M., Lehtonen, Š., Kuusisto, J., Pietiläinen, O. P. H., Saber, S. H., et al. (2023) · Journal of Virology · doi:10.1128/jvi.00144-23 · Cited by 31
Pandamooz, S., Jurek, B., Meinung, C.-P., Baharvand, Z., Shahem-abadi, A. S., Haerteis, S., Miyan, J. A., Downing, J. R., Dianatpour, M., Borhani‐Haghighi, A., et al. (2021) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-121120-012309 · Cited by 31
Highlights in the fight against COVID-19: does autophagy play a role in SARS-CoV-2 infection?
Delorme‐Axford, E., & Klionsky, D. J. (2020) · Autophagy · doi:10.1080/15548627.2020.1844940 · Cited by 32
Carius, P., Jungmann, A., Bechtel, M., Grißmer, A., Boese, A. S., Gasparoni, G., Salhab, A., Seipelt, R. G., Urbschat, K., Richter, C., et al. (2023) · Advanced Science · doi:10.1002/advs.202207301 · Cited by 30
COVID-19 Usurps Host Regulatory Networks
Curran, C. S., Rivera, D. R. R., & Kopp, J. B. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01278 · Cited by 31
Metadata
- Authors
- HCA Lung Biological Network, Sungnak, W., Huang, N., Bécavin, C., Berg, M., Queen, R., Litvinukova, M., Talavera-López, C., Maatz, H., Reichart, D., Sampaziotis, F., Worlock, K. B., Yoshida, M., & Barnes, J. L.
- Affiliations
- Wellcome Sanger Institute (GB)
- Centre National de la Recherche Scientifique (FR)
- University Medical Center Groningen (NL)
- Max Delbrück Center (DE)
- Harvard University (US)
- Wellcome/MRC Cambridge Stem Cell Institute (GB)
- University College London (GB)
- Corresponding author
- Sungnak, Waradon
- ORCID
- Venue
- Nature Medicine
- Published
- 2020-04-23
- Volume
- 26
- Issue
- 5
- Pages
- 681-687
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- PMC
- PMC8637938
- OpenAlex
- W3011483298
- Cited by
- 2,501
- References
- 59
- Citations by year
- 2026: 53 · 2025: 105 · 2024: 140 · 2023: 265 · 2022: 454 · 2021: 814 · 2020: 664
- FWCI
- 71.69
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Nature Medicine (publishedVersion, other-oa)
- PubMed (publishedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion, other-oa)
- Repository of the Academy's Library (Library of the Hungarian Academy of Sciences) (acceptedVersion)
- PubMed Central (acceptedVersion)
- arXiv (Cornell University) (submittedVersion)
- Työväentutkimus Vuosikirja (submittedVersion)
- Archivio Istituzionale della Ricerca - Università degli Studi dell Aquila (submittedVersion, public-domain)
- Apollo (University of Cambridge) (submittedVersion)
- HAL (submittedVersion)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Site cant be reached (submittedVersion)
- PuSH - Publication Server of Helmholtz Zentrum München (submittedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
- Apollo
- Funders
- U.S. Department of Defense (W81XWH1910416)
- Howard Hughes Medical Institute
- U.S. Department of Veterans Affairs
- Bill and Melinda Gates Foundation
- Richard and Susan Smith Family Foundation
- Massachusetts General Hospital
- Yale University
- Vanderbilt University
- Massachusetts Institute of Technology
- Memorial Sloan-Kettering Cancer Center
- Northwestern University
- School of Medicine, Boston University
- Arizona State University
- Helsingin Yliopisto
- University of Washington
- Deutsches Zentrum für Infektionsforschung
- Wellcome Trust (211276/Z/18/Z, 211276/D/18/Z, 108082/A/15/Z, #MR/R006237/1, WT206194, 107931/Z/15/Z, GINOP-2.3.2-15-2016-00026, WT211276/Z/18/Z)
- Deutsches Zentrum für Herz-Kreislaufforschung
- European Bioinformatics Institute
- National Jewish Health
- Vanderbilt University Medical Center
- European Molecular Biology Laboratory
- Broad Institute
- Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology
- Manton Foundation
- University of Alberta
- Cancer Research UK
- National Institute for Health and Care Research (PB-PG-1215-20037, CL-2017-14-001)
- British Heart Foundation (SP/19/1/34461, PG/16/47/32156)
- Cystic Fibrosis Trust (VIA 028)
- Academy of Medical Sciences (SGL019\1071)
- Imperial College London (H2020)
- University College London
- Newcastle University
- European Commission (2018-342, GINOP‐2.3.2‐15‐2016‐00037, 874656, GINOP-2.3.2-15-2016-00006, H2020)
- Rosetrees Trust
- National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC/T2T0419, NC/N001540/1)
- National Research Foundation
- Deutsche Forschungsgemeinschaft (347286815, DK043351, EXC2151/1, EXC 2151, 329123747, 390873048)
- Agence Nationale de la Recherche (ANR‐10‐INBS‐09‐03, ANR- 10-INBS-09, ANR‐19, ANR-19-CE14, ANR-19-CE14-0027, ANR-10, 10-INBS-09, -15-IDEX-01, ANR‐15‐IDEX‐01)
- Fondation Leducq
- Rijksuniversiteit Groningen
- University of New South Wales
- National Natural Science Foundation of China (31871370)
- Catholic University of Korea
- Cancerfonden (2019-)
- Fondation pour la Recherche Médicale (DEQ20180339158)
- National Research Foundation of Korea
- Karolinska Institutet
- National Science and Technology Development Agency
- Kungliga Tekniska Högskolan
- Vetenskapsrådet (2018-)
- Thailand Research Fund
- Centre National de la Recherche Scientifique
- Universitair Medisch Centrum Groningen
- Deutsches Zentrum für Neurodegenerative Erkrankungen
- Medizinischen Hochschule Hannover
- Rheinische Friedrich-Wilhelms-Universität Bonn
- Stockholms Universitet
- Science for Life Laboratory
- Conseil Départemental des Alpes Maritimes (2016-294DGADSH-CV)
- Deutsches Zentrum für Lungenforschung
- National Centre for the Replacement Refinement and Reduction of Animals in Research (NC/N001540/1)
- Ministerie van Economische Zaken en Klimaat
- Berlin Institute of Health
- National Institutes of Health (1r56hl135124-01, H2020, AG‐049665, DK 043351, AI135964)
- Directorate for Biological Sciences
- School of Medicine, Duke University
- School of Medicine, Stanford University
- University of California, San Diego
- Harvard Stem Cell Institute
- Feinberg School of Medicine
- Medical School, University of Michigan
- Horizon 2020 Framework Programme (874656, GINOP-2.3.2)
- Klarman Cell Observatory, Broad Institute
- Medical Research Council (MC_PC_17230, MR/R015635/1, MR/P009581/1, MC_PC_12009, MR/R006237/1, MR/K017047/1, MR/S005579/1)
- Engineering and Physical Sciences Research Council (TS/H001220/1)
- Biotechnology and Biological Sciences Research Council (BB/T004460/1, BB/V01126X/1)
- National Health and Medical Research Council
- Faculty of Medical Sciences, Newcastle University
- European Regional Development Fund (GINOP‐2.3.2‐15‐2016‐00006, H2020, GINOP-2.3.2-15-2016-00037, GINOP-2.3.2-15-2016-00026)
- NIHR Newcastle Biomedical Research Centre
- Helmholtz Zentrum München
- NIHR Cambridge Biomedical Research Centre
- National Institute on Aging (P01AG049665)
- National Heart, Lung, and Blood Institute (HL135124, R01HL146557, U01HL148856, R56 HL135124, K08HL130595, K08HL146943, HL148856, U01HL145567, R01HL145372, R01HL127349)
- National Institute of Allergy and Infectious Diseases (U24AI118672, U19AI135964)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK043351)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R24HD000836)
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Single-cell and spatial transcriptomics
- Keywords
- SARS-CoV-2, viral entry factors, ACE2, TMPRSS2, nasal epithelial cells, innate immunity, respiratory epithelium, corneal epithelium, intestinal epithelium, tissue tropism, COVID-19 pandemic, single-cell transcriptomics, gene co-expression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
